Medscape (8/2, Brooks) reports an analysis by a WHO-led global advisory group concluded “dementia prevention, risk reduction, and delivery of high-quality care are global dementia research priorities.” The World Alzheimer Report 2015 found that the number of people living with dementia globally is “expected to rise from the current 46 million to 131.5 million by 2050.” Global treatment costs are estimated to jump from $818 billion in 2015 to $1 trillion by 2018 and $2 trillion by 2030. The WHO analysis, which included input from over 200 researchers and stakeholders, concluded a series of “overarching research goals.” Among the top 10 overall research priorities include “prevention, identification and reduction of dementia risk, and delivery and quality of care for dementia patients and their caregivers.”
Related Links:
— Medscape (requires login and subscription)